Bharat Biotech International Limited (BBIL) recently stated X that the company unintentionally omitted the Indian Council of Medical Research (ICMR) as a co-owner of the inactivated COVAXIN® vaccine patent.
On June 22, 2024, the Hyderabad-based vaccine producer Tweeted that it was taking legal action to correct this issue.
According to media reporting, ICMR was to receive a 5% royalty on net sales and product branding rights, which include 'co-inventor' status.
Read More
